公司資料
KALA BIO 股價、新聞與催化劑
- 股票代碼:
- KALA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.82 USD (-2.38%)
收盤價
最後更新: 2026年8月21日
44.4M USD
市值
股價為何變動
As of Aug 21, 2026, KALA closed down 2.38% at $0.8201. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
KALA BIO is an eye-care biotechnology company focused on corneal and ocular surface disease. Its story centers on developing therapies for chronic ophthalmic conditions with limited treatment options.
所在地與產業分類
KALA BIO is headquartered in the United States and listed on NASDAQ. It sits in ophthalmology biotechnology.
商業模式特徵
The company depends on clinical progress, regulatory milestones, and the ability to commercialize a focused eye-care pipeline. Investors watch data, safety, and access strategy.
生技產業定位
KALA occupies a niche ophthalmology position within biotech. It is catalyst-sensitive because eye-disease programs often hinge on a narrow set of data events.
未來催化劑
- KALA Bio is largely a legacy / closeout story, so the catalysts are any remaining strategic or asset-resolution update. There is no live standalone growth story left.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。